Post-marketing Surveillance Study of the Effectiveness and Safety of new Oral Antivirals for outpatients with mild-moderate COVID-19. (ESOA-19)First published 18/07/2022 Last updated 23/04/2024 EU PAS number: EUPAS48186StudyPlanned
Porto Pharmacovigilance Centre, Faculty of Medicine, University of Porto (UFPorto)Portugal First published: 17/11/2010Last updated 12/06/2023 InstitutionEducational InstitutionENCePP partner